<- Go home

Added to YB: 2020-12-19

Pitch date: 2020-12-19

BYSI:US [bullish]

BeyondSpring Inc.

-81.87%

current return

Author Info

No bio for this author

Company Info

BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on the development of cancer therapies.

Market Cap

$85.5M

Pitch Price

$11.64

Price Target

N/A

Dividend

N/A

EV/EBITDA

-10.84

P/E

-10.92

EV/Sales

N/A

Sector

Biotechnology

Category

N/A

Show full summary:
BEYONDSPRING INC COM BYSI:US

A summary for this pitch has not been created yet.

Read full article (0 min)